THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS

Objective: Bisphosphonates are pyrophosphate analogs with a high affinity for calcium crystals. Due to the affinity of bisphosphonates for calcium, they bind rapidly to calcium-containing hydroxyapatite crystals, especially in the resorption zone. In this way, they prevent bone resorption. In this s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ayşe Uysal, Mustafa Merter, Serhat Göçüncü
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/65dad6aaf61a40759dfd643744d47e14
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:65dad6aaf61a40759dfd643744d47e14
record_format	dspace
spelling	oai:doaj.org-article:65dad6aaf61a40759dfd643744d47e142021-11-10T04:36:18ZTHE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS2531-137910.1016/j.htct.2021.10.1042https://doaj.org/article/65dad6aaf61a40759dfd643744d47e142021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921011895https://doaj.org/toc/2531-1379Objective: Bisphosphonates are pyrophosphate analogs with a high affinity for calcium crystals. Due to the affinity of bisphosphonates for calcium, they bind rapidly to calcium-containing hydroxyapatite crystals, especially in the resorption zone. In this way, they prevent bone resorption. In this study, we aimed to investigate the effect of bisphosphonate use on treatment response and overall survival in patients with MM. Methodology: All patients with MM who followed by the Hematology department of Fırat University Hospital in the last 10 years were included in this retrospective observational study. Age, gender, end-organ involvement, ISS staging, LDH level, IG subtype in diagnosis, bisphosphonate use (duration and dose), treatments, response status and survival was investigated. Results: Ninety-one patients, of whom 53 were male and 38 females, were included in this study. At the time of diagnosis,14 patients with high calcium, 77 patients had normal calcium. There was no significant difference in survival between bisphosphonate intake status and IG subtypes (p>0,05). There was no significant difference in progression-free survival between the ISS category, bisphosphonate intake status, creatinine category, and IG subtypes (p>0,05). Conclusion: In this study, OS, and PFS in MM patients were not affected by bisphosphonate use. however, LDH level influenced both OS and PFS, the increase in LDH level negatively affected the survival.Ayşe UysalMustafa MerterSerhat GöçüncüElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S44-S45 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Ayşe Uysal Mustafa Merter Serhat Göçüncü THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
description	Objective: Bisphosphonates are pyrophosphate analogs with a high affinity for calcium crystals. Due to the affinity of bisphosphonates for calcium, they bind rapidly to calcium-containing hydroxyapatite crystals, especially in the resorption zone. In this way, they prevent bone resorption. In this study, we aimed to investigate the effect of bisphosphonate use on treatment response and overall survival in patients with MM. Methodology: All patients with MM who followed by the Hematology department of Fırat University Hospital in the last 10 years were included in this retrospective observational study. Age, gender, end-organ involvement, ISS staging, LDH level, IG subtype in diagnosis, bisphosphonate use (duration and dose), treatments, response status and survival was investigated. Results: Ninety-one patients, of whom 53 were male and 38 females, were included in this study. At the time of diagnosis,14 patients with high calcium, 77 patients had normal calcium. There was no significant difference in survival between bisphosphonate intake status and IG subtypes (p>0,05). There was no significant difference in progression-free survival between the ISS category, bisphosphonate intake status, creatinine category, and IG subtypes (p>0,05). Conclusion: In this study, OS, and PFS in MM patients were not affected by bisphosphonate use. however, LDH level influenced both OS and PFS, the increase in LDH level negatively affected the survival.
format	article
author	Ayşe Uysal Mustafa Merter Serhat Göçüncü
author_facet	Ayşe Uysal Mustafa Merter Serhat Göçüncü
author_sort	Ayşe Uysal
title	THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
title_short	THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
title_full	THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
title_fullStr	THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
title_full_unstemmed	THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
title_sort	effect of bisphosphonate use on treatment response and overall survival in multiple myeloma patients
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/65dad6aaf61a40759dfd643744d47e14
work_keys_str_mv	AT ayseuysal theeffectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients AT mustafamerter theeffectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients AT serhatgocuncu theeffectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients AT ayseuysal effectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients AT mustafamerter effectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients AT serhatgocuncu effectofbisphosphonateuseontreatmentresponseandoverallsurvivalinmultiplemyelomapatients
_version_	1718440564250116096

THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS

Ejemplares similares